Madhav Biotech Private Limited
Pharmaceutical company manufacturing and exporting patented medicines, drugs, cosmetics, and herbs.
2006 | H P, Himachal Pradesh (India) | Active
Madhav Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 23.98%
- Profit Growth 88.73%
- Ebitda 70.12%
- Net Worth -0.36%
- Total Assets -91.74%
About Madhav Biotech
Madhav Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2006 and has a history of 18 years and 11 months. Its registered office is in H P, Himachal Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jyothi Lakkireddy and Lakkireddy Reddy serve as directors at the Company.
Company Details
- Location H P, Himachal Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U45202HP2006PTC029865
- Company No.
029865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2006
- Date of AGM
20 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Pharma
Who are the key members and board of directors at Madhav Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyothi Lakkireddy  | Director | 25-Mar-2015 | Current |
| Lakkireddy Reddy | Director | 09-Mar-2006 | Current |
Financial Performance of Madhav Biotech.
Madhav Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 23.98% increase. The company also saw a substantial improvement in profitability, with a 88.73% increase in profit. The company's net worth dipped by a decrease of 0.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madhav Biotech?
In 2021, Madhav Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Gvr Pharma Private Limited
Jyothi Lakkireddy and Lakkireddy Reddy are mutual person
- Vensat Bio Private Limited
Lakkireddy Reddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Madhav Biotech?
Unlock and access historical data on people associated with Madhav Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madhav Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madhav Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
